Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma. RMS often arise from myogenic precursors and displays a poorly differentiated skeletal muscle phenotype most closely resembling regenerating muscle. GSK3β is a ubiquitously expressed serine-threonine kinase capable of repressin...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Bharathy, Narendra, Svalina, Matthew N., Settelmeyer, Teagan P., Cleary, Megan M., Berlow, Noah E., Airhart, Susan D., Xiang, Sunny, Keck, James, Hayden, James B., Shern, Jack F., Mansoor, Atiya, Lathara, Melvin, Srinivasa, Ganapati, Langenau, David M., Keller, Charles
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2017
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5609896/
https://ncbi.nlm.nih.gov/pubmed/28968964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18520
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍